LiteVax
Akkersestraat 50
4061Bj Ophemert
NL
LiteVax
Foundation date
24/05/2012
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more
-
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Read more